Tag:
Conatus Pharmaceuticals
Latest Headlines
Latest Headlines
Adverse events force Conatus to shelve PhII study of lead HCV therapy
Earlier this year San Diego-based Conatus Pharmaceuticals was able to round up a $32.5 million B round from a group of venture backers which included Roche Ventures, largely based on the promise of
Chimerix funds antiviral drug work with $45M round
With two antiviral drug candidates in the clinic, Durham, NC-based Chimerix has raised $45 million in a Series F round of financing. New Leaf Venture Partners led the round. The firm was joined by
